Skip to main content

Table 1 General characteristics of the study participants

From: Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: a randomized, clinical trial

Variable

Taurine group (n = 60)

Placebo group (n = 60)

P-value

Age (years)a

52.13 ± 8.1

53.08.1 ± 8.8

0.686d

Gender [17]b

48 (80)

49 (81)

0.500

Weighta (kg) at study baseline

78.88 ± 8.3

79.2 ± 9.1

0.835d

Weight (kg) after intervention

75.44 ± 9.4

77.10 ± 8.2

0.315

BMI at study baseline

27.94 ± 6.9

28.01 ± 7.1

0.835d

BMI after intervention

26.80 ± 9.4

27.25 ± 8.2

0.225

Diabetes duration (years)

5.1 ± 1.3

4.9 ± 1.2

0.407

Active Smokingb

5 (8)

4 (6)

0.650c

Physical activity (METs)

773.7 ± 198.3

760.6 ± 201.21

0.830

Metformin use, n (%)

48 (80)

47 (78)

0.499

Glibenclamide use, n (%)

33 (53)

31 (49)

0.580

  1. METs: Metabolic equivalents (MET-minutes/week); MD: Mean/Median of difference
  2. aValues are expressed as mean ± SD
  3. bValues are expressed as frequency (%)
  4. cChi-square test
  5. dIndependent samples t-test